Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism

Juengel,Eva; Afschar,Masud; Makarević,Jasmina; Rutz,Jochen; Tsaur,Igor; Mani,Jens; Nelson,Karen; Haferkamp,Axel; Blaheta,Roman  A.

doi:10.3892/ijmm.2016.2454

Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism

Authors:
- Eva Juengel
- Masud Afschar
- Jasmina Makarević
- Jochen Rutz
- Igor Tsaur
- Jens Mani
- Karen Nelson
- Axel Haferkamp
- Roman A. Blaheta
View Affiliations

Affiliations: Department of Urology, Goethe-University Hospital, Frankfurt am Main, Germany, Department of Vascular and Endovascular Surgery, Goethe-University Hospital, Frankfurt am Main, Germany
Published online on: January 8, 2016 https://doi.org/10.3892/ijmm.2016.2454
Pages: 843-850

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Information about the natural compound amygdalin, which is employed as an antitumor agent, is sparse and thus its efficacy remains controversial. In this study, to determine whether amygdalin exerts antitumor effects on renal cell carcinoma (RCC) cells, its impact on RCC metastatic activity was investigated. The RCC cell lines, Caki-1, KTC-26 and A498, were exposed to amygdalin from apricot kernels, and adhesion to human vascular endothelium, immobilized collagen or fibronectin was investigated. The influence of amygdalin on chemotactic and invasive activity was also determined, as was the influence of amygdalin on surface and total cellular α and β integrin expression, which are involved in metastasis. We noted that amygdalin caused significant reductions in chemotactic activity, invasion and adhesion to endothelium, collagen and fibronectin. Using FACScan analysis, we noted that amygdalin also induced reductions, particularly in integrins α5 and α6, in all three cell lines. Functional blocking of α5 resulted in significantly diminished adhesion of KTC-26 and A498 to collagen and also in decreased chemotactic behavior in all three cell lines. Blocking α6 integrin significantly reduced chemotactic activity in all three cell lines. Thus, we suggest that exposing RCC cells to amygdalin inhibits metastatic spread and is associated with downregulation of α5 and α6 integrins. Therefore, we posit that amygdalin exerts antitumor activity in vitro, and this may be linked to integrin regulation.

View Figures

View References

1	Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE and Davignon JP: A clinical trial of amygdalin (laetrile) in the treatment of human cancer. N Engl J Med. 306:201–206. 1982. View Article : Google Scholar : PubMed/NCBI
2	Newell GR and Ellison NM: Ethics and designs: laetrile trials as an example. Cancer Treat Rep. 64:363–365. 1980.PubMed/NCBI
3	van Zijl F, Krupitza G and Mikulits W: Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 728:23–34. 2011. View Article : Google Scholar : PubMed/NCBI
4	Sun CC, Qu XJ and Gao ZH: Integrins: players in cancer progression and targets in cancer therapy. Anticancer Drugs. 25:1107–1121. 2014. View Article : Google Scholar : PubMed/NCBI
5	Makarević J, Rutz J, Juengel E, Kaulfuss S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A and Blaheta RA: Amygdalin influences bladder cancer cell adhesion and invasion in vitro. PLoS One. 9:e1102442014. View Article : Google Scholar
6	Makarević J, Rutz J, Juengel E, Kaulfuss S, Reiter M, Tsaur I, Bartsch G, Haferkamp A and Blaheta RA: Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2. PLoS One. 9:e1055902014. View Article : Google Scholar
7	Salvo E, Garasa S, Dotor J, Morales X, Peláez R, Altevogt P and Rouzaut A: Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer. Mol Cancer. 13:1122014. View Article : Google Scholar
8	White NM, Masui O, Newsted D, Scorilas A, Romaschin AD, Bjarnason GA, Siu KW and Yousef GM: Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis. Br J Cancer. 110:1250–1259. 2014. View Article : Google Scholar : PubMed/NCBI
9	Juengel E, Makarević J, Reiter M, Mani J, Tsaur I, Bartsch G, Haferkamp A and Blaheta RA: Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism. Neoplasia. 16:291–300. 2014. View Article : Google Scholar : PubMed/NCBI
10	Tsaur I, Makarević J, Juengel E, Gasser M, Waaga-Gasser AM, Kurosch M, Reiter M, Wedel S, Bartsch G, Haferkamp A, et al: Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells. Br J Cancer. 107:847–855. 2012. View Article : Google Scholar : PubMed/NCBI
11	Imanishi Y, Hu B, Jarzynka MJ, Guo P, Elishaev E, Bar-Joseph I and Cheng SY: Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res. 67:4254–4263. 2007. View Article : Google Scholar : PubMed/NCBI
12	Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K and Lengyel E: Ligand-independent activation of c-Met by fibronectin and α(5) β(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene. 30:1566–1576. 2011. View Article : Google Scholar :
13	Lityńska A, Przybyło M, Pocheć E and Laidler P: Adhesion properties of human bladder cell lines with extracellular matrix components: the role of integrins and glycosylation. Acta Biochim Pol. 49:643–650. 2002.
14	Ricci E, Mattei E, Dumontet C, Eaton CL, Hamdy F, van der Pluije G, Cecchini M, Thalmann G, Clezardin P and Colombel M: Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression. Prostate. 73:1738–1746. 2013. View Article : Google Scholar : PubMed/NCBI
15	Chao C, Lotz MM, Clarke AC and Mercurio AM: A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res. 56:4811–4819. 1996.PubMed/NCBI
16	Cruz-Monserrate Z and O'Connor KL: Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent Rac activation. Neoplasia. 10:408–417. 2008. View Article : Google Scholar : PubMed/NCBI
17	Kim TH, Kim HI, Soung YH, Shaw LA and Chung J: Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion. Mol Cancer Res. 7:1605–1612. 2009. View Article : Google Scholar : PubMed/NCBI
18	Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE and Hemler ME: Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res. 70:2256–2263. 2010. View Article : Google Scholar : PubMed/NCBI
19	Lee S, Qiao J, Paul P and Chung DH: Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion. Surgery. 154:369–375. 2013. View Article : Google Scholar : PubMed/NCBI
20	Khalili P, Arakelian A, Chen G, Plunkett ML, Beck I, Parry GC, Doñate F, Shaw DE, Mazar AP and Rabbani SA: A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Cancer Ther. 5:2271–2280. 2006. View Article : Google Scholar : PubMed/NCBI
21	Tsaur I, Rutz J, Makarević J, Juengel E, Gust KM, Borgmann H, Schilling D, Nelson K, Haferkamp A, Bartsch G and Blaheta RA: CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro. World J Urol. 33:1051–1056. 2015. View Article : Google Scholar
22	Zutter MM, Santoro SA, Staatz WD and Tsung YL: Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA. 92:7411–7415. 1995. View Article : Google Scholar : PubMed/NCBI
23	Cagnet S, Faraldo MM, Kreft M, Sonnenberg A, Raymond K and Glukhova MA: Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis. Oncogene. 33:4286–4295. 2014. View Article : Google Scholar
24	Lee S, Qiao J, Paul P, O'Connor KL, Evers MB and Chung DH: FAK is a critical regulator of neuroblastoma liver metastasis. Oncotarget. 3:1576–1587. 2012. View Article : Google Scholar : PubMed/NCBI
25	Tringali C, Lupo B, Silvestri I, Papini N, Anastasia L, Tettamanti G and Venerando B: The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling. J Biol Chem. 287:42835–42845. 2012. View Article : Google Scholar : PubMed/NCBI